Location of Repository

Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights

By Margaret G Distler, Margaret G Distler and Abraham A Palmer and Abraham A Palmer

Abstract

Glyoxalase 1 (GLO1) is a ubiquitous cellular enzyme that participates in the detoxification of methylglyoxal (MG), a cyotoxic byproduct of glycolysis that induces protein modification (advanced glycation end-products, AGEs), oxidative stress, and apoptosis. The concentration of MG is elevated under high-glucose conditions, such as diabetes. As such, GLO1 and MG have been implicated in the pathogenesis of diabetic complications. Recently, findings have linked GLO1 to numerous behavioral phenotypes, including psychiatric diseases (anxiety, depression, schizophrenia, and autism) and pain. This review highlights GLO1’s association with behavioral phenotypes, describes recent discoveries that have elucidated the underlying mechanisms, and identifies opportunities for future research

Topics: Anxiety, Behavior, Depression, Pain, Schizophrenia, autism, Genetics, QH426-470
Publisher: Frontiers Media S.A.
Year: 2012
DOI identifier: 10.3389/fgene.2012.00250
OAI identifier: oai:doaj.org/article:0b614b1adc684041a7681c47808560e9
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1664-8021 (external link)
  • http://journal.frontiersin.org... (external link)
  • https://doaj.org/article/0b614... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.